InsiderClue
Insiders · Profile

Waddill William D.

Director at Protagonist Therapeutics · Director at ARROWHEAD PHARMACEUTICALS. Filing since 11 Jan 2019. CIK 0001553338

PTGX Protagonist Therapeutics, Inc Director · 12 trades ARWR ARROWHEAD PHARMACEUTICALS, INC. Director · 10 trades
Company
Date
Role
Action
Shares
Amount
Of holding
PTGX Protagonist Therapeutics, Inc
23 Jun 2026
Director
Sold on a plan
9,000
$1.06M
53.5%
PTGX Protagonist Therapeutics, Inc
10 Jun 2026
Director
Sold on a plan
9,000
$969.12K
53.5%
PTGX Protagonist Therapeutics, Inc
29 May 2026
Director
Sold on a plan
9,000
$896.76K
53.5%
PTGX Protagonist Therapeutics, Inc
6 Feb 2026
Director
Sold at will
20,000
$1.67M
71.9%
ARWR ARROWHEAD PHARMACEUTICALS, INC.
19 Dec 2025
Director
Sold on a plan
8,367
$566.04K
12.9%
PTGX Protagonist Therapeutics, Inc
10 Oct 2025
Director
Sold on a plan
12,000
$979.48K
70.1%
PTGX Protagonist Therapeutics, Inc
22 Sep 2025
Director
Sold on a plan
4,000
$257.00K
43.8%
PTGX Protagonist Therapeutics, Inc
27 Aug 2025
Director
Sold on a plan
4,000
$237.00K
30.5%
PTGX Protagonist Therapeutics, Inc
17 Mar 2025
Director
Sold on a plan
4,000
$217.00K
23.4%
ARWR ARROWHEAD PHARMACEUTICALS, INC.
17 Dec 2024
Director
Sold on a plan
3,747
$82.58K
8.5%
ARWR ARROWHEAD PHARMACEUTICALS, INC.
16 Dec 2024
Director
Sold on a plan
3,748
$82.08K
7.8%
PTGX Protagonist Therapeutics, Inc
10 Sep 2024
Director
Sold on a plan
8,000
$360.00K
40.0%
PTGX Protagonist Therapeutics, Inc
24 Jul 2024
Director
Sold on a plan
8,000
$320.00K
40.0%
PTGX Protagonist Therapeutics, Inc
7 Jun 2024
Director
Sold on a plan
8,000
$280.00K
40.0%
PTGX Protagonist Therapeutics, Inc
1 Mar 2024
Director
Sold on a plan
12,975
$406.64K
52.0%
ARWR ARROWHEAD PHARMACEUTICALS, INC.
11 Jan 2024
Director
Sold on a plan
3,934
$149.76K
7.6%
ARWR ARROWHEAD PHARMACEUTICALS, INC.
9 Jan 2023
Director
Sold, plan not stated
3,200
$96.00K
10.0%
ARWR ARROWHEAD PHARMACEUTICALS, INC.
3 Jan 2022
Director
Sold, plan not stated
4,500
$291.24K
14.9%
ARWR ARROWHEAD PHARMACEUTICALS, INC.
4 Jan 2021
Director
Sold, plan not stated
3,750
$285.30K
11.0%
ARWR ARROWHEAD PHARMACEUTICALS, INC.
10 Dec 2020
Director
Sold, plan not stated
3,000
$213.78K
10.7%
ARWR ARROWHEAD PHARMACEUTICALS, INC.
11 May 2020
Director
Sold, plan not stated
26,000
$950.04K
48.1%
ARWR ARROWHEAD PHARMACEUTICALS, INC.
11 Jan 2019
Director
Sold, plan not stated
8,500
$125.55K
15.5%
22 decisions on file.